Capstone Therapeutics Cor...

NASDAQ: CAPS · Real-Time Price · USD
1.09
-0.05 (-4.39%)
At close: Aug 19, 2025, 3:58 PM
1.07
-1.83%
After-hours: Aug 19, 2025, 07:03 PM EDT

Capstone Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
44.88M 48.35M 61.56M 66.74M
Cost of Revenue
35.31M 38.74M 45.03M 50.43M
Gross Profit
9.57M 9.61M 16.53M 16.32M
Operating Income
-638K -1.26M 3.99M 4.64M
Interest Income
n/a n/a n/a n/a
Pretax Income
-5.94M -3.58M 3.1M 4.36M
Net Income
-2.56M -3.82M 2.31M 3.92M
Selling & General & Admin
10.21M 10.87M 12.54M 11.68M
Research & Development
n/a n/a n/a n/a
Other Expenses
n/a n/a n/a n/a
Operating Expenses
10.21M 10.87M 12.54M 11.68M
Interest Expense
1.48M 1.53M 895K 1.06M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
45.51M 49.61M 57.57M 62.11M
Income Tax Expense
-442K 234K 783K 436K
Shares Outstanding (Basic)
157.61K 157.61K 157.61K 79.28K
Shares Outstanding (Diluted)
157.61K 157.61K 157.61K 79.28K
EPS (Basic)
-34.86 -36.39 14.69 49.46
EPS (Diluted)
-34.86 -36.39 14.69 49.46
EBITDA
-121K -1.75M 4.23M 5.02M
EBIT
-638K -2.06M 3.99M 4.64M
Depreciation & Amortization
517K 306K 241K 386K